ASX - By Stock
|
KZA |
Re:
Excellent interim DIPG data from PNOC
|
|
CrazyShad
|
21 |
6.5K |
0 |
12/11/23 |
12/11/23 |
ASX - By Stock
|
21
|
6.5K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Paxalisib receives Fast Track Designation from US FDA
|
|
CrazyShad
|
42 |
13K |
0 |
27/07/23 |
27/07/23 |
ASX - By Stock
|
42
|
13K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Paxalisib receives Fast Track Designation from US FDA
|
|
CrazyShad
|
42 |
13K |
2 |
25/07/23 |
25/07/23 |
ASX - By Stock
|
42
|
13K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Positive melanoma data for Kazia's paxalisib
|
|
CrazyShad
|
48 |
14K |
4 |
03/11/22 |
03/11/22 |
ASX - By Stock
|
48
|
14K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
The End-of-the-Road for Immunotherapies in GBM CheckMate 498
|
|
CrazyShad
|
13 |
4.0K |
0 |
07/05/22 |
07/05/22 |
ASX - By Stock
|
13
|
4.0K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Kazia Therapeutics investor briefing
|
|
CrazyShad
|
7 |
2.0K |
0 |
06/10/20 |
06/10/20 |
ASX - By Stock
|
7
|
2.0K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia Notice of Annual General Meeting/Proxy Form
|
|
CrazyShad
|
11 |
4.2K |
1 |
15/10/19 |
15/10/19 |
ASX - By Stock
|
11
|
4.2K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia Annual Report
|
|
CrazyShad
|
146 |
52K |
0 |
07/10/19 |
07/10/19 |
ASX - By Stock
|
146
|
52K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia Annual Report
|
|
CrazyShad
|
146 |
52K |
0 |
07/10/19 |
07/10/19 |
ASX - By Stock
|
146
|
52K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia completes recruitment to Cantrixil Phase 1 trial
|
|
CrazyShad
|
70 |
40K |
1 |
14/08/19 |
14/08/19 |
ASX - By Stock
|
70
|
40K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Share Price
|
|
CrazyShad
|
137 |
33K |
3 |
28/06/19 |
28/06/19 |
ASX - By Stock
|
137
|
33K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
Selling
|
|
CrazyShad
|
178 |
48K |
1 |
17/06/19 |
17/06/19 |
ASX - By Stock
|
178
|
48K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
closer day by day
|
|
CrazyShad
|
13 |
4.4K |
1 |
06/05/18 |
06/05/18 |
ASX - By Stock
|
13
|
4.4K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia presentation to Proactive Investors CEO series
|
|
CrazyShad
|
79 |
28K |
2 |
20/03/18 |
20/03/18 |
ASX - By Stock
|
79
|
28K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
Might be worth watching
|
|
CrazyShad
|
3 |
1.9K |
2 |
16/02/18 |
16/02/18 |
ASX - By Stock
|
3
|
1.9K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
Yale Research Video
|
|
CrazyShad
|
10 |
4.1K |
6 |
11/02/18 |
11/02/18 |
ASX - By Stock
|
10
|
4.1K
|
6
|
|
ASX - By Stock
|
KZA |
Re:
Yale Research Video
|
|
CrazyShad
|
10 |
4.1K |
0 |
11/02/18 |
11/02/18 |
ASX - By Stock
|
10
|
4.1K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Any Cantrixil Updates/Info?
|
|
CrazyShad
|
46 |
12K |
1 |
21/12/17 |
21/12/17 |
ASX - By Stock
|
46
|
12K
|
1
|
|
ASX - By Stock
|
KZA |
Any Cantrixil Updates/Info?
|
|
CrazyShad
|
46 |
12K |
3 |
16/12/17 |
16/12/17 |
ASX - By Stock
|
46
|
12K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Novogen licence programs to Heaton Brown Life Sciences
|
|
CrazyShad
|
39 |
12K |
4 |
14/11/17 |
14/11/17 |
ASX - By Stock
|
39
|
12K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
Nice work James Garner
|
|
CrazyShad
|
60 |
15K |
1 |
10/11/17 |
10/11/17 |
ASX - By Stock
|
60
|
15K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
New Life
|
|
CrazyShad
|
62 |
23K |
1 |
03/11/17 |
03/11/17 |
ASX - By Stock
|
62
|
23K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Novogen Annual Report and Corporate Governance Statement
|
|
CrazyShad
|
72 |
18K |
2 |
27/10/17 |
27/10/17 |
ASX - By Stock
|
72
|
18K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Novogen Annual Report and Corporate Governance Statement
|
|
CrazyShad
|
72 |
18K |
2 |
27/10/17 |
27/10/17 |
ASX - By Stock
|
72
|
18K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Novogen Annual Report and Corporate Governance Statement
|
|
CrazyShad
|
72 |
18K |
2 |
27/10/17 |
27/10/17 |
ASX - By Stock
|
72
|
18K
|
2
|
|